Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intellia Thera CS
(NQ:
NTLA
)
23.83
+0.83 (+3.61%)
Streaming Delayed Price
Updated: 10:27 AM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Intellia Thera CS
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
5 Reasons Alnylam's Still a Top Biotech Stock to Buy Now
July 01, 2021
Despite a threat from Intellia on the horizon, Alnylam's still in a position to deliver big gains for patient investors.
Via
The Motley Fool
Apellis, Beam Ink $75M Deal To Test Base Gene Editing Against Complement Disorders
July 01, 2021
Beam Therapeutics Inc (NASDAQ: BEAM) joins forces with Apellis Pharmaceuticals Inc (NASDAQ: APLS) to create new gene-editing treatments for complement-driven...
Via
Benzinga
72 Biggest Movers From Yesterday
July 01, 2021
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share. Cuentas Inc. (NASDAQ: CUEN...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Analyst Ratings For Intellia Therapeutics
June 29, 2021
Within the last quarter, Intellia Therapeutics (NASDAQ:NTLA
Via
Benzinga
'Halftime Report' Traders Share Their Thoughts On Crispr Therapeutics And Bed Bath & Beyond
June 30, 2021
Amy Raskin said on CNBC's "Fast Money Halftime Report" that she would hold Crispr Therapeutics AG (NASDAQ: CRSP). She doesn't own the stock, but she owns...
Via
Benzinga
Why Intellia Therapeutics Was a Winner on Wednesday
June 30, 2021
The company is about to fatten its coffers significantly.
Via
The Motley Fool
In Future CRISPR Gene Editing To Treat Diseases, Says Intellia Co-Founder: CNBC
June 30, 2021
Gene-editing technology CRISPR reached a significant milestone this week, completing its first systemic delivery as a medicine to the human body. What Happened: On Monday,...
Via
Benzinga
Gene Editing Stocks: Why EDIT, CRSP, NTLA Stocks Continue to Soar
June 30, 2021
Today, gene editing stocks are soaring amid increasingly bullish sentiment in this sector following strong results from Intellia.
Via
InvestorPlace
Why Gene Editing Stocks Are Trading Higher Again Today
June 30, 2021
Shares of gene editing stocks are continuing higher in sympathy with peer company Intellia (NASDAQ: NTLA), which gained in recent sessions following positive data for its...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 30, 2021
Gainers Dare Bioscience (NASDAQ:DARE) stock moved upwards by 26.82% to $2.08 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume...
Via
Benzinga
51 Stocks Moving In Wednesday's Mid-Day Session
June 30, 2021
Gainers Cuentas Inc. (NASDAQ: CUEN) shares jumped 176.6% to $7.69. The stock spiked following a press release saying "WaveMax to Implement the World's First Shared Wifi6...
Via
Benzinga
Unusual Options Activity Insight: Intellia Therapeutics
June 30, 2021
Shares of Intellia Therapeutics (NASDAQ:NTLA) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $183.36. Sentiment...
Via
Benzinga
Stocks That Hit 52-Week Highs On Wednesday
June 30, 2021
This morning 132 companies reached new 52-week highs. Noteworthy Mentions: The largest company by market cap to break to a new 52-week high was NVIDIA (NASDAQ:NVDA...
Via
Benzinga
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
June 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Intellia Therapeutics Stock Moves Higher After Capital Raise Of $600M Issued At $145/Share
June 30, 2021
Intellia Therapeutics Inc (NASDAQ: NTLA) has priced a previously announced public offering at $145 per share, representing a discount of 4.4% from the last close...
Via
Benzinga
Can Intellia Therapeutics Turn Exciting Trial Results into Profits?
June 30, 2021
New proof-of-concept results are a big deal for the medical community, but what about for your portfolio?
Via
The Motley Fool
Exposures
COVID-19
58 Biggest Movers From Yesterday
June 30, 2021
Gainers BSQUARE Corporation (NASDAQ: BSQR) shares jumped 206.9% to close at $8.04 on Tuesday on abnormally-high volume possibly amid increased attention from retail investors....
Via
Benzinga
Why Regeneron Pharmaceuticals Analyst Says Competitive Concerns Are Overblown, Pipeline Opportunity Underappreciated
June 29, 2021
Regeneron Pharmaceuticals Inc.'s (NASDAQ:REGN) robust ...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
June 29, 2021
Barclays raised the price target for Skyworks Solutions, Inc. (NASDAQ:
Via
Benzinga
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
June 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...
Via
Benzinga
22 Stocks Moving in Tuesday's Pre-Market Session
June 29, 2021
Gainers Exela Technologies, Inc. (NASDAQ: XELA) rose 39% to $2.05 in pre-market trading after gaining over 5% on Monday. Marin Software Incorporated (NASDAQ: MRIN) rose 36.8% to...
Via
Benzinga
Intellia Seeks To Raise $400M Via Equity
June 29, 2021
Intellia Therapeutics Inc (NASDAQ: NTLA) commenced an underwritten public offering of $400 million shares of its common stock. Underwriters have an option to...
Via
Benzinga
60 Biggest Movers From Yesterday
June 29, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its...
Via
Benzinga
Intellia Therapeutics Analyst Doubles Price Target: What You Need To Know
June 28, 2021
An SVB Leerink genetic medicine analyst is bullish on shares of Intellia Therapeutics, Inc. (NASDAQ:
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Gains 100 Points; New Senior Investment Shares Spike Higher
June 28, 2021
Toward the end of trading Monday, the Dow traded down 0.49% to 34,266.49 while the NASDAQ rose 0.72% to 14,463.26. The S&P also rose, gaining 0.05% to 4,283.04. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Intellia Makes a Splash, Bringing Other CRISPR Stocks Along for the Ride
June 28, 2021
Intellia's recent press release reveals first-of-its-kind clinical results for genome editing technology, leading NTLA stock skyward.
Via
InvestorPlace
Ignoring Monday's 2 Big Nasdaq Winners Could Cost You Serious Money
June 28, 2021
Find out why these stocks are climbing higher.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
June 28, 2021
Gainers Intellia Therapeutics (NASDAQ:NTLA
Via
Benzinga
Mid-Day Market Update: Crude Oil Down Over 1%; Intellia Therapeutics Shares Jump
June 28, 2021
Midway through trading Monday, the Dow traded down 0.52% to 34,253.86 while the NASDAQ rose 0.72% to 14,463.56. The S&P also fell, dropping 0.01% to 4,280.50. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Beam Therapeutics Jumped Today
June 28, 2021
A first for CRISPR-Cas9 might signal a new phase in the gene-editing revolution.
Via
The Motley Fool
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.